All News

In a trial, 91% of patients rated Sutab as very easy to tolerable to consume, and 78% said they would request Sutab again for a future colonoscopy.

Higher fitness levels reduced the risk of developing atrial fibrillation by up to 50% in a study of Black male veterans.

For hospital pharmacies, the COVID-19 pandemic sparked an abrupt and intensive reevaluation of nearly every aspect of their operations.

Compared with a placebo, deucravacitinib was more effective in treating plaque psoriasis.

Despite presenting in only 18% of cases, 16% of all COVID-19 patients only present with gastrointestinal symptoms.

Palm oil contains abundant quantities of vitamin E compounds, which include tocopherols and tocotrienols.

Glenmark Pharmaceutical’s tacrolimus drug product is the generic version of Astellas Pharma’s Prograf Capsules.

Pharmacists can help play an integral role in appropriate medication use for older people by optimizing medication therapeutic effects and reducing adverse effects.

Trial that is evaluating the efficacy, safety, and immunogenicity of NVX-CoV2373 in COVID-19 is expected to be fully enrolled by the end of November.

Itraconazole Oral Solution is an antifungal medication that is used in adults to treat infections caused by fungus.

Further, the study showed cabotegravir was 89% more effective than daily oral FTC/TDF for pre-exposure prophylaxis (PrEP).

Further, the study showed cabotegravir was 89% more effective than daily oral FTC/TDF for pre-exposure prophylaxis (PrEP).

Not only did cognitive behavioral therapy help insomnia, it also improved symptoms of depression and anxiety.

In partnership with Pharmacy Times and Florajen, take the quiz to enter the raffle!

The rising global death toll, in addition to the economic consequences of the pandemic, have led many calls to mandate a COVID-19 vaccination if and when a vaccine is approved.

According to lead study author Melissa Melough, as many as 80% of Black pregnant women in the United States may be deficient in vitamin D.

The transmission of COVID-19 depends almost entirely on human behavior, meaning temperature and humidity do not play a significant role, study suggests.

Pharmacists and other medical experts also have a great opportunity to use social media to correct misconceptions, provide guidance, and steer patients toward credible sources.

Statin use in certain patients may lead to increased muscle pain so severe it can affect adherence.

Frequent or chronic use of oral corticosteroids can lead to serious adverse effects in patients with asthma, including weight gain, diabetes, immunosuppression, and adrenal insufficiency.

Investigational COVID-19 antibody was authorized in a 700 mg dose for adults and pediatric patients 12 years and older and should be administered as soon as possible after diagnosis and within 10 days of symptom onset.

The FDA approved FoundationOne Liquid CDx as a companion diagnostic with olaparib for certain patients with metastatic castration-resistant prostate cancer.

A new study suggests that COVID-19 antibodies remain in the body for up to 5 months.

Even in a relatively asymptomatic case of COVID-19, it is possible that the virus could have fostered retrograde reactivation of the varicella-zoster virus.

Maintaining brain health is especially important in the senior population, because once brain cells die, dementia typically follows.

Pfizer and BioNTech plan for submission to the FDA for an Emergency Use Authorization soon after the required safety milestone is achieved in mid-November for a promising novel COVID-19 vaccine candidate.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Sleep deficiency may impair the ability to cognitively filter intrusive memories and thoughts when confronted with reminders of them, according to a recent study.

The processes involving the high prevalence of diagnosis and over prescription undoubtedly play a role, but it is possible that the infra-diagnosis and lower prescription rates in men could be a factor, according to the study authors.

Janssen Pharmaceutical Companies submitted a supplemental New Drug Application (sNDA) to the FDA to expand the use of rivaroxaban in patients with peripheral artery disease.